Why Montana for Bioscience

Discover a world of opportunities under the Big Sky. Montana is a performance-driven bioscience ecosystem where research, commercialization, and advanced manufacturing converge. With federal research assets, two R1 universities, statewide collaboration, and leading funding success rates, Montana is a strategic alternative to crowded coastal hubs.

The Montana Advantage

Montana’s unique regulatory environment, cost efficiencies, and collaborative research ecosystem accelerate commercialization and de-risk investments—delivering scalable opportunities for institutional and strategic biotech investors.

Montana laboratory and research environment

Business-Friendly Regulations

Montana provides a regulatory and tax environment favorable to capital‑intensive, research-driven firms. Bioscience companies benefit from streamlined permitting, pragmatic regulators, and a state government focused on long-term life sciences growth—offering greater predictability for project timelines, costs, and risks than crowded coastal jurisdictions.

Montana universities and hospitals collaboration

Collaboration Among Industry, Hospitals, Labs, and Universities

Montana’s scale lets executives reach decision-makers at Rocky Mountain Laboratories, leading hospitals, and R1 universities without heavy bureaucracy. Industry, clinical, and academic partners routinely align on priorities—from infectious disease to rural health and agricultural biotech—speeding partnership formation, multi-site trials, and translational research.

Biotech manufacturing facility in Montana

Faster Commercialization

In coastal markets, early-stage bioscience ventures compete for lab space, pilot manufacturing, talent, and executive attention. In Montana, innovators have direct access to decision-makers, lab resources, and commercialization support. University licensing teams are focused on moving technologies to market, and regulatory reviews, facility build-outs, and partnerships often proceed faster because stakeholders prioritize outcomes over process.

Cost-effective bioscience facilities in Montana

Cost Advantages

Montana lets bioscience organizations extend runway and invest more in R&D, talent, and growth. Real estate for office, lab, and light manufacturing is generally cheaper than major coastal metros, and operating costs—from utilities to services—are more manageable, enabling scalable operations without compromising quality or compliance.

Montana bioscience workforce and training

Strong Workforce Pipeline

Montana’s two R1 universities anchor a growing pipeline of graduates in bioscience, engineering, data science, and health professions, supported by technical college programs for lab operations, manufacturing, and quality systems. Employers access workers with technical skills, practical problem‑solving, and familiarity with regulated environments—key for labs, manufacturing, and supply chain roles.

A Great Place to Live and Work

Montana offers a powerful quality-of-life advantage that strengthens its bioscience ecosystem. With access to iconic natural landscapes like Yellowstone and Glacier National Parks, safe and engaged communities, advanced healthcare systems, and vibrant cultural amenities, the state supports both personal well-being and professional productivity. Combined with a more attainable cost of living compared to major coastal markets, Montana helps employers attract and retain skilled talent while enabling employees to achieve long-term stability

Montana’s Momentum in Bioscience

Montana’s bioscience sector has passed an inflection point and is scaling around federal research assets, industry anchors, and supportive policy. Instead of sheer company count, Montana wins on velocity, quality, and capital efficiency.

#1

in Bioscience Employment Growth

Montana ranks #1 in percent employment growth in bioscience nationwide. The state leads the nation in bioscience employment momentum, with a 14.6% industry employment increase since 2019. Growth spans research, testing, medical laboratories, pharmaceutical and vaccine manufacturing, agricultural and industrial biosciences, and related distribution and devices—supporting 29,722 direct and indirect bioscience jobs statewide.

29,722

Bioscience-Supported Jobs

Global industry has invested here: GSK’s $100M expansion for vaccine manufacturing demonstrates Montana’s capacity for complex, regulated biopharma production and signals long-term workforce, infrastructure, regulatory, and community support.

$39.9M

NIH funding in 2023

In 2023 Montana investigators and institutions secured $39.9M in NIH funding—a strong result for a state of this size. That federal investment supports Rocky Mountain Laboratories, Montana State University, the University of Montana, private institutes, and hospital-based research, creating a pipeline from discovery to clinical studies.

48%

NIH SBIR success rate

Montana outperforms national averages in federal innovation programs. A 48% NIH SBIR funding success rate—and the highest SBIR/STTR award rate nationally—reflects an ecosystem skilled at turning science into investable innovations. Entrepreneurs benefit from targeted technical assistance, aligned mentors, and a commercialization-focused culture.

A Century of Innovation in Montana

Montana’s bioscience sector is built on more than a century of scientific leadership. Long before “biotech” became an industry category, Montana scientists were shaping the global understanding of infectious disease, microbiology, and human health. That legacy continues to inform the state’s credibility with federal partners, investors, and multinational companies evaluating where to place high-consequence research and development programs.

1910s–Today

Rocky Mountain Laboratories

100+ years advancing infectious disease research, vaccines, therapeutics, and global health security.
Late 20th Century

Origin of biofilm science

Montana researchers reshape understanding of microbial communities and their impact on health and industry.
Modern Era

Neurodegenerative research

McLaughlin Research Institute advances science and potential therapeutics for Alzheimer’s and related disorders.
Today & Beyond

Dual R1 universities

Montana State University and the University of Montana drive research, commercialization, and talent creation.

Rocky Mountain Laboratories: 100+ years of infectious disease expertise

Rocky Mountain Laboratories (RML), part of the National Institutes of Health, has been at the forefront of infectious disease research for over a century. From early work on vector-borne diseases to contemporary studies of emerging pathogens, RML has earned global recognition as a trusted, technically advanced research institution. Its work has informed vaccines, therapeutics, and public health strategies worldwide, anchoring Montana’s reputation as a serious contributor to global health security.

RML is also home to an NIH Level IV laboratory, one of the highest-containment research environments in the world. This facility supports work with high-risk pathogens and positions Montana at the center of preparedness and response efforts for current and future biological threats. For companies and collaborators, proximity to this capability offers unique partnership, validation, and translational research opportunities that are not widely available in other states.

Origin of biofilm technology

Montana researchers played a pivotal role in defining and advancing biofilm science—work that has reshaped how the world understands microbial communities and their impact on health, industry, and the environment. Innovations in biofilm technology originating in Montana have informed new strategies for infection control, medical device design, and industrial processes, further solidifying the state’s place in foundational bioscience discovery.

McLaughlin Research Institute: advancing neurodegenerative research

The McLaughlin Research Institute contributes to Montana’s reputation in neuroscience and neurodegenerative disease. Its investigators focus on understanding the mechanisms underlying conditions such as Alzheimer’s and related disorders, and on translating that understanding into potential therapeutic approaches. The institute’s work demonstrates how an independent research organization in Montana can operate at a high scientific standard while remaining deeply integrated into the state’s broader bioscience ecosystem.

Two R1 universities driving research and commercialization

Montana State University and the University of Montana are both designated R1 research universities—an uncommon concentration of research intensity for a state of Montana’s size. Montana State University ranks in the top 3% of colleges and universities for research expenditures, averaging approximately $100M annually, and maintains deep expertise across biosciences, engineering, and computational fields. The University of Montana complements this with strengths in biomedical, health, and environmental sciences, along with programs that bridge basic research and public health practice.

Together, these two R1 institutions generate a critical mass of bioscience discovery, talent, and intellectual property. An estimated 55% of all academic research in Montana is bioscience related, underscoring how central life sciences are to the state’s research identity. For companies, this means a steady flow of potential collaborations, licensing opportunities, and graduates prepared for roles in research, testing, and medical laboratories; drugs and pharmaceuticals; medical devices and equipment; and agricultural and industrial biosciences.

This combination of long-standing federal research, independent institutes, and R1 universities creates a powerful continuum: legacy → credibility → innovation pipeline. Montana’s history in bioscience is not simply a story of past achievements; it is the foundation for the next generation of discoveries, startups, and strategic partnerships in Montana bioscience.

Partner with Montana BioScience Alliance

Whether you are evaluating sites for a new facility, exploring collaborations with Rocky Mountain Laboratories research teams, assessing investment opportunities in Montana biotech companies, or planning the next phase of your innovation strategy, Montana BioScience Alliance is your first call. We connect you with the people, data, and partners you need to make confident, long-term decisions in Montana bioscience.

Engage with us to:

Understand the full landscape of bioscience assets and opportunities in Montana
Explore partnerships with universities, hospitals, labs, and established Montana biotech companies
Navigate SBIR/STTR and other non-dilutive funding pathways with local expertise
Identify talent, training, and workforce solutions tailored to your growth plans
Coordinate with state and local leaders on infrastructure and community support

View Membership

Now is the time to consider Montana for bioscience. The fundamentals are in place, the momentum is measurable, and the opportunities span research, development, manufacturing, and distribution. Montana BioScience Alliance stands ready to be your guide, partner, and advocate as you explore what is possible in life sciences Montana.